OK Biotech Co (TPE:4155) ROE % Adjusted to Book Value: 10.64% (As of Dec. 2025)


TPE:4155 OK Biotech Co Ltd TPE:4155
61 GF Score
Price NT$15.50
GF Value NT$27.26
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is OK Biotech Co ROE % Adjusted to Book Value?

OK Biotech Co TPE:4155 +1.31% 61 ROE % Adjusted to Book Value is 10.64% as of Dec. 2025. GuruFocus rates TPE:4155 with a GF Score™ of 61/100 and a GF Value™ of NT$27.26 (Possible Value Trap). The stock has 7 warning signs investors should review.

OK Biotech Co's ROE % for the quarter that ended in Dec. 2025 was 8.62%. OK Biotech Co's PB Ratio for the quarter that ended in Dec. 2025 was 0.81. OK Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 10.64%.

OK Biotech Co ROE % Adjusted to Book Value Related Terms

OK Biotech Co ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for OK Biotech Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co ROE % Adjusted to Book Value Chart

OK Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.98 5.42 0.09 3.17 4.06

OK Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 3.63 -13.48 16.01 10.64

TPE:4155 vs ABT, SYK, MDT: ROE % Adjusted to Book Value Comparison

For the Medical Devices subindustry, OK Biotech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OK Biotech Co ROE % Adjusted to Book Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OK Biotech Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where OK Biotech Co's ROE % Adjusted to Book Value falls into.


TPE:4155
61GF Score
OK Biotech Co Ltd TPE:4155
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OK Biotech Co ROE % Adjusted to Book Value Calculation

OK Biotech Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=3.29% / 0.81
=4.06%

OK Biotech Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.62% / 0.81
=10.64%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 10.64% mean?
OK Biotech Co (TPE:4155) has a ROE % Adjusted to Book Value of 10.64% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on OK Biotech Co and its competitors.
Is OK Biotech Co's ROE % Adjusted to Book Value too high?
OK Biotech Co's current ROE % Adjusted to Book Value is 10.64%. Overall, OK Biotech Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's ROE % Adjusted to Book Value compare to ABT and SYK?
OK Biotech Co's ROE % Adjusted to Book Value of 10.64% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Devices & Instruments company?
A good ROE % Adjusted to Book Value depends on the Medical Devices & Instruments industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current ROE % Adjusted to Book Value is 10.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.26, compared to a current price of NT$15.50 — trading 43.1% below its estimated fair value. The current ROE % Adjusted to Book Value is 10.64%. OK Biotech Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current ROE % Adjusted to Book Value is 10.64% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OK Biotech Co (TPE:4155) Overvalued in 2026?

Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued. The current stock price of NT$15.50 is trading 43.1% below its estimated GF Value™ of NT$27.26. GuruFocus considers OK Biotech Co to be Possible Value Trap.

Key valuation signals for TPE:4155:

  • ROE % Adjusted to Book Value: 10.64%
  • GF Value™: NT$27.26 vs. price of NT$15.50 (43.1% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OK Biotech Co Business Description

Address Gongdao 5th Road, Section 2, No. 91, Hsinchu, TWN, 30070
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
61GF Score

Get the complete analysis for TPE:4155

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.50
Price
NT$27.26
GF Value